1. AMLs harboring DNMT3A-destabilizing variants show increased intratumor DNA methylation heterogeneity at bivalent chromatin domains
- Author
-
Dohoon Lee, Bonil Koo, Seok-Hyun Kim, Jamin Byun, Junshik Hong, Dong-Yeop Shin, Choong-Hyun Sun, Ji-Joon Song, Jaesung Kim, Siddhartha Jaiswal, Sung-Soo Yoon, Sun Kim, and Youngil Koh
- Abstract
The mechanistic link between the complex mutational landscape ofde novomethyltransferaseDNMT3Aand the pathology of acute myeloid leukemia (AML) has not been clearly elucidated so far. A recent discovery on the catalogue of DNMT3A-destabilizing mutations throughout theDNMT3Agene as well as the oligomerization-dependent catalytic property of DNMT3A prompted us to investigate the common effect of DNMT3A-destabilizing mutations (DNMT3AINS) on the genomewide methylation patterns of AML cells. In this study, we describe the characteristics ofDNMT3AINSAML methylomes through the comprehensive computational analyses on three independent AML cohorts. As a result, we show that methylomes ofDNMT3AINSAMLs are considerably different from those ofDNMT3AR882AMLs in that they exhibit both locally disordered DNA methylation states and increased across-cell DNA methylation heterogeneity in bivalent chromatin domains. This increased epigenetic heterogeneity was functionally associated with heterogeneous expression of membrane-associated factors shaping stem cell niche, implying the diversification of the modes of leukemic stem cell-niche interactions. We also present that the level of methylation disorder at bivalent domains predicts the response of AML cells to hypomethylating agents through cell line- and patient-level analyses, which supports that the survival of AML cells depends on stochastic DNA methylations at bivalent domains. Altogether, our work provides a novel mechanistic model suggesting the genomic origin of the aberrant epigenomic heterogeneity in disease conditions.
- Published
- 2023
- Full Text
- View/download PDF